COMP <GO>
ZBIO vs AGIO // OPERATING MARGIN
Zenas BioPharma Inc. (NASDAQ) VS. Agios Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: ZBIO 4
— AGIO 2
■ METRIC PARITY
LAST: $27.62 (-2.71%) • MKT CAP: $1.85B
operating-margins
-60.00%
LAST: $29.95 (-1.96%) • MKT CAP: $1.82B
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZBIO VS. AGIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZBIO | AGIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -33.80% | -1.20 | AGIO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.19% | -16.97% | +7.78 | ZBIO | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 100.00% | 48.00% | +52.00 | ZBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.79 | 11.84 | -9.05 | AGIO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 42.5 | +9.50 | ZBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.85B | $1.82B | $26.5M | ZBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZBIO REV | AGIO REV | ZBIO GROSS % | AGIO GROSS % | ZBIO FCF | AGIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.0M | $54.0M | — | 88.3% | -$172.4M | -$377.3M |
| FY 2024 | $5.0M | $36.5M | — | 88.6% | -$119.8M | -$391.5M |
| FY 2023 | $50.0M | $26.8M | — | — | -$30.5M | -$296.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZBIO // BETA —
AGIO // BETA —